An interventional study of FES-assisted gait training in Spinal Cord Injuries, sponsored by Stichting Reade. Completed at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2024-12-18.
Sponsored by Stichting Reade · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 22 studies in Spinal Cord Injuries with a site in Netherlands — 5 open to participants now, 6 under way, none of them phase 3. Spinal Cord Injuries · Netherlands.
Among the 22 studies in Spinal Cord Injuries with a site in Netherlands, this one is the 16th largest by enrollment of the 18 interventional ones that give a count, is one of 5 that started in 2023, is one of 17 with no phase, and was the 12th registered.
2,032 studies on the registry are indexed under Spinal Cord Injuries; 542 are open to participants now.
Browse Spinal Cord Injuries studies →5 of the 22 studies in Spinal Cord Injuries with a site in Netherlands are open now. Recruiting first, the newest first:
UMC Utrecht · Sites in Netherlands
Ages 18–70
ABLE Human Motion S.L. · Sites in Netherlands
Ages 18+
Annemie Spooren · Sites in Netherlands, Belgium
Ages 16–90
ONWARD Medical, Inc. · Sites in Netherlands
Ages 18+
Stichting Reade · Sites in Netherlands
Ages 17–85
A study can be open while its sites in Netherlands have not opened yet or have stopped. Only those recruiting at a site in Netherlands →
Of the 374 Spinal Cord Injuries studies recruiting now, 167 (45%) set no upper age limit and 156 (42%) stop at 75 or younger; 40 take children under 18; 52 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
22 studies; the count open now beside each. This study's row is marked.
First in 2012; this study’s year is marked. 5 started in 2023.
This study's enrollment of 5 is below the median of 24 across 1,639 interventional studies indexed under Spinal Cord Injuries.
Median enrollment 18 across the 18 interventional studies, 33 across the 4 observational. Of the 14 that completed or were terminated, 1 (7%) have results posted.
This tab as a report to print or save as PDF → With an account.
6 of 22 have an industry lead sponsor. The 10 most frequent:
Stichting Reade is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Stichting Reade has 3 studies filed under Spinal Cord Injuries — fewer than ten, so there is no comparison to draw.
3 of the studies in Spinal Cord Injuries with a site in Netherlands that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06065384Annemie SpoorenNeural Plasticity and Motor Recovery After Upper Extremity Motor Training in People With c-SCI | 2027-03-28 |
| NCT07645144Stichting ReadeFES-assisted Gait Training for Incomplete Spinal Cord Injury | 2027-04-01 |
| NCT07640711UMC UtrechtInnovative Brain-Computer Interface for People With Spinal Cord Injury | 2027-08 |
Add all 3 to your calendar (.ics) → With an account.
Among the 22 studies in Spinal Cord Injuries with a site in Netherlands, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
A spinal cord injury (SCI) disrupts the communication within the nervous system, leading to limitations in sensorimotor activities such as walking. Regular use of functional electrical stimulation (FES) can result in recovery of voluntary muscle control and muscle strength. Locomotor training with FES may be a promising method to improve gait function. The primary objective of this pilot study is to assess the feasibility and safety of an FES-assisted gait training intervention. Secondary objectives are to assess the effects of an FES-assisted gait training intervention on gait function.
A spinal cord injury (SCI) disrupts the communication within the nervous system, leading to limitations in sensorimotor activities, such as walking. These limitations are associated with muscle weakness, a disturbance of the reflex activity, and the inability or difficulty to recruit muscles below the lesion. Regular use of functional electrical stimulation (FES) can result in recovery of voluntary muscle control and muscle strength. Studies that investigated the effect of locomotor training on a treadmill with functional electrical stimulation and/or body weight support (BWS) show improved function of the lower limbs. FES-assisted gait therapy may be a promising method for improving gait function in individuals with an incomplete SCI. Therefore, this study will investigate if an FES-assisted gait (with BWS) is feasible and safe. This study will also investigfate if an FES-assisted gait can improve gait function in people with an incomplete SCI.
Primary objective of this pilot study is to assess the feasibility and safety of an FES-assisted gait training intervention. The secondary objectives are to assess the effects of an FES-assisted gait training intervention on gait function.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
FES-assisted gait training intervention group
Other: FES-assisted gait training
The participants will walk with functional electrical stimulation (and possible body weight support) on a treadmill for 10 weeks, twice a week for 30 minutes.
Feasibility of the intervention
Self-administered questionnaires about the training sessions, preceived effect, applicability of FES and the experience with walking with FES.
Time frame: Assessed during week 11 during the post-intervention measurement.
Incidence of (Serious) Adverse Events [Safety of the Intervention]
The total number of (serious) adverse events
Time frame: Assessed during week 1 to 10 for each FES-assisted gait training session (2x week) and in week 0, week 11 and week 21 (during the pre-, post- and follow-up measurements)
Change in average and maximum treadmill walking speed
Average and maximum walking speed (m/s) recorded by the treadmill during each training session
Time frame: Assessed during each FES-assisted gait training session (from week 1 until week 10, 2x a week)
Change in distance
Distance (in meters) recorded by the treadmill during each training session.
Time frame: Assessed during each FES-assisted gait training session (from week 1 until week 10, 2x a week)
Change in average overground walking speed
Walking speed (m/s) measured by 10 meter walk test
Time frame: Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)
Change in muscle activity
Surface EMG measurement during 10 meter walk test. Time of muscle activation and duration of muscle activity of the m. rectus femoris, m. vastus lateralis, m. semitendinosus, m. tibialis anterior, m. gastrocnemius medialis, m. soleus and m. peroneus longus
Time frame: Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)
Change in step length
Step length left and right (cm) measured during 10 meter walk test with the interactive walkway (kinect)
Time frame: Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)
Change in step width
Step width (cm) measured during 10 meter walk test with interactive walkway (kinect)
Time frame: Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)
Change in cadence
Cadence (steps/min) measured during 10 meter walk test with interactive walkway (kinect)
Time frame: Assessed before and after the 10-weeks FES-assisted gait training intervention (during week 0 and week 11)
Plan to share: No
No publications or documents are linked to this record.
Ran from May 2023 to primary completion in Jun 2024, 12 months.
Of 791 non-industry interventional studies with no phase under Spinal Cord Injuries, half reached primary completion within 37 months of starting (the median), counting those still running; a quarter within 18 and three quarters within 65. This study's 12 months is below that.
Counting every sponsor, half of 840 studies reached it within 36 months; a quarter within 17 and three quarters within 64.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.